HOME >> MEDICINE >> NEWS
Viagra used in stroke recovery study

DETROIT - Henry Ford Hospital has launched a safety study using the drug Viagra to determine if it can help patients recover from a stroke.

The study, launched this week and approved by the U.S. Food and Drug Administration, aims to help individuals regain or improve motor and speech skills as well as cognitive thinking. Viagra, or sildenafil, is a commonly prescribed drug for erectile dysfunction.

"We realized that we need to look at what we can do to help people who have had a stroke get their lives back," says Brian Silver, M.D., principal investigator and a neurologist at Henry Ford Hospital.

The hospital will enroll 84 patients in the study. Participants must be over age 18 and have suffered a moderate stroke within 72 hours of being placed in a study group.

Henry Ford Hospital has used Viagra for two Michigan patients for neurological recovery, both under a compassionate use basis.

One patient, Rene Jarinski, 43, has been treated with Viagra since suffering a stroke in July 2003. Transferred to Henry Ford from another hospital, she was diagnosed with locked in syndrome, a very uncommon condition, in which she could only move her eyes up down.

"To my knowledge she is the first patient in the United States who has been treated with Viagra specifically for stroke recovery," says Dr. Silver.

After being given doses of 50 and 100 milligrams early on, she now takes 150 milligrams daily.

"We're not certain that Viagra is helping the recovery, but she is now able to smile, eat, move all four limbs and stand up with assistance," says Silver. "Things moved slowly in the first couple of months; most of the recovery has come after the sixth month period. This is very uncommon for individuals after stroke who typically see a deceleration in recovery. Individuals with locked in syndrome rarely walk or talk again. Rene is making a recovery that doesn't follow the normal recovery curve."

Dr. Silv
'"/>

Contact: Dwight Angell
dangell1@hfhs.org
313-876-8709
Henry Ford Health System
17-Feb-2005


Page: 1 2 3

Related medicine news :

1. U of M researcher says Viagra may cause permanent vision loss in some men
2. Younger men lead surge in Viagra use, study reveals
3. Viagra (R) can take effect in as little as 14 minutes in many men, study shows
4. Viagra for alleviation of pulmonary hypertension?
5. Viagra helps men with heart failure
6. First study of Viagra(R) in black men demonstrates treatment as effective, well tolerated
7. Viagra significantly effective, well-tolerated for men taking multiple blood pressure treatments
8. Mayo Clinic study shows no adverse heart effect for sildenafil (Viagra)
9. Beyond Viagra: other phosphodiesterase inhibitors are candidates for potential therapies
10. Viagra Prescribing Will Be Based On Financial Rather Than Clinical Reasoning
11. UK Faculty Members Find Way To Speed Response Of Viagra

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Viagra used stroke recovery study

(Date:5/21/2013)... Spring is the perfect time to ... filled with whole foods to weather perfect for outdoor ... season the nutrition experts at Brilliant Nutrition highlight five ... , 1. Eating Locally, With the abundance of fresh ... and explore, spring is a great time to take ...
(Date:5/21/2013)... Standard advice for mattress shoppers often consists ... given industry’s less than exceptional satisfaction ratings and the ... Consumer Mattress Reports sets out to revise this advice ... .” , This article addresses several components of the ... not be readily apparent to many shoppers. From prices ...
(Date:5/21/2013)... Patients of Dr. Michael Shenk and Dr. Judd Shenk ... gum disease and would like permanent tooth replacements now have ... laser gum surgery. Gum disease must be treated prior ... of all tooth replacement options. , The Laser Assisted ... by the Food and Drug Administration (FDA) that greatly improves ...
(Date:5/21/2013)... analogues (PGAs), drugs which lower intraocular pressure, are often ... but their use is not without risks. PGAs have ... eye color and other side effects. Now a new ... and lower eyelid drooping and other issues that can ... PLOS ONE . , Researchers from the Massachusetts Eye ...
(Date:5/21/2013)... 2013 HealthSmart continues to grow through ... has required the hiring of new talent in several ... to announce that Dawn Powell has joined the organization ... Director of Account Management in the Central Region and ... Texas. With extensive client management, employee benefits, and product ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2
(Date:5/21/2013)... May 21, 2013 BioElectronics Corp. (PINKSHEETS: ... electronic devices, announced that CEO, Andrew ... the FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation ... for over the counter sales. "It,s ... medical device classification schema," Whelan said.  "While the ...
(Date:5/21/2013)... TARRYTOWN, N.Y. , May 21, 2013 ... Inc. (NASDAQ: REGN) today announced that the New ... Phase 2a study results of dupilumab (SAR231893/REGN668) in patients ... antibody targeting the alpha subunit of the interleukin 4 ... and IL-13, drivers of Th2 (Type 2 helper T ...
(Date:5/21/2013)... 2013 U.S. spending on specialty prescription drugs ... as cancer, multiple sclerosis and rheumatoid arthritis — is ... 2015, according to a forecast released today by Express ... ) "As we see what,s on ... to act so they can continue to offer an ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5
Cached News: